Clinical Trials Browser

Phase 2 × Pharmacogenomic Variants × Thoracic × Clear all

NCT03520842 2023-08-01

Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer

Phase 2 Completed

22 enrolled 20 charts

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung